Research and Markets: Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a57396/taiwan_diabetes_ca) has announced the addition of GlobalData 's new report "Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" to their offering.

“Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery”

GlobalData's new report, Taiwan Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the Taiwan Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

• Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the Taiwan Diabetes Care Devicesmarket.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Taiwan Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned:

• F. Hoffmann-La Roche Ltd.
• Novo Nordisk A/S
• LifeScan, Inc.
• Sanofi
• Eli Lilly and Company
• TaiDoc Technology Corporation
• Apex Biotechnology Corp.
• Becton, Dickinson and Company
• Medtronic, Inc.
• ARKRAY, Inc.
• Abbott Laboratories
• Animas Corporation
• NIPRO CORPORATION
• BIONIME Corporation

For more information visit http://www.researchandmarkets.com/research/a57396/taiwan_diabetes_ca